Search Results - "Ibrahim, Bashaar Al"

Peroral endoscopic myotomy (POEM) for the treatment of achalasia: A multicenter Middle Eastern experience by Al Lehibi, Abed, Elkholy, Shaimaa, Gouda, Mohamed, Al Dabbagh, Ammar, Al Balkhi, Areej, Almtawa, Abdullah, Al Otaibi, Nawwaf, El-Sherbiny, Mohammed, Essam, Kareem, Alzahrani, Mohammed, Al Ghamdi, Ahmed, Al Ghamdi, Adel, AlEid, Ahmad, Qutub, Adel, Alamr, Abdulrahman, Ahmad, Shameem, Al Sayari, Khalid, Al Ibrahim, Bashaar, Al Khathlan, Abdullah, Alkhiari, Resheed

“…Background: Peroral endoscopic myotomy (POEM) was proposed in 2010 as a minimally invasive procedure for the treatment of achalasia. In this article, we…”
Get full text

Prevalence and Risk Factors of Cytomegalovirus Colitis in Inflammatory Bowel Disease Patients in Riyadh, Saudi Arabia: A Tertiary Center Experience by Alotaibi, Yazeed, AlLehibi, Abed, Almtawa, Abdullah, Alotaibi, Nawaf, Alghamdi, Adel, Alrajhi, Saad, AlQutub, Adel, AlEid, Ahmad, Alamr, Abdulrhman, Ibrahim, Bashaar Al, Alahmari, Mohammed, Alhamidi, Hussam, Ahmad, Shameem, Alshammari, Fouad, Almotawa, Fahad, Altannir, Youssef, Alghamdi, Ahmed

“…Background: Patients with inflammatory bowel disease (IBD) are at a higher risk of cytomegalovirus (CMV) colitis because of their immunocompromised status…”
Get full text

Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease by Buffone, Elisa, Gupta, Shaan, Al Ibrahim, Bashaar, Marshall, John K., Halder, Smita, Tse, Frances, Albashir, Siwar, Morgan, David, Lumb, Barry, Armstrong, David, Narula, Neeraj

“…The role of early proactive therapeutic drug level monitoring for anti-tumor necrosis factor therapies is unclear. We aimed to determine whether a week 2 serum…”
Get full text

Infliximab‐induced autoimmune hepatitis requiring liver transplantation by Wong, Frederick, Al Ibrahim, Bashaar, Walsh, Joanna, Qumosani, Karim

“…Autoimmune hepatitis is an infrequent but significant side effect of infliximab treatment. Diagnosis of autoimmune hepatitis is based on clinical, laboratory,…”
Get full text

The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life (HRQoL) in treatment-naïve, non-cirrhotic, genotype 4-infected patients (ELEGANT-4): A single-center, single-arm, open-label, phase 3 trial by AlEid, Ahmad, Al Balkhi, Areej, Qutub, Adel, Abbarh, Shahem, AlLehibi, Abed, Almtawa, Abdullah, Al Otaibi, Nawwaf, AlGhamdi, Ahmed, AlGhamdi, Adel, Alamr, Abdulrahman, Ahmad, Shameem, Al Sayari, Khalid, Al Ibrahim, Bashaar, AlKhathlan, Abdullah

“…Background: Cost, adverse events, and long treatment duration can be significant obstacles in treating hepatitis C virus (HCV)-infected individuals. Shortening…”
Get full text

Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease by Buffone, Elisa, Gupta, Shaan, Al Ibrahim, Bashaar, Marshall, John K., Halder, Smita, Tse, Frances, Albashir, Siwar, Morgan, David, Lumb, Barry, Armstrong, David, Narula, Neeraj

Get full text

The efficacy of Elbasvir/Grazoprevir fixed-dose combination for 8 weeks in HCV treatment and health-related quality of life : A single-center, single-arm, open-label, phase 3 trial by AlEid, Ahmad, Balkhi, Areej Al, Qutub, Adel, Abbarh, Shahem, AlLehibi, Abed, Almtawa, Abdullah, Otaibi, Nawwaf Al, AlGhamdi, Ahmed, AlGhamdi, Adel, Alamr, Abdulrahman, Ahmad, Shameem, Sayari, Khalid Al, Ibrahim, Bashaar Al, AlKhathlan, Abdullah

Get full text

Tu1833 – Week 2 Adalimumab Level Predicts Short-Term Clinical Remission in Patients with Ibd by IBRAHIM, BASHAAR K. AL, Gupta, Shaan, Marshall, John K., Halder, Smita L., Tse, Frances, Albashir, Siwar M., Morgan, David G., Lumb, Barry, Armstrong, David, Narula, Neeraj

Get full text

Infliximab-induced autoimmune hepatitis requiring liver transplantation by Wong, Frederick, Al Ibrahim, Bashaar, Walsh, Joanna, Qumosani, Karim

Get full text